Vinay Prasad’s exit — his second from the agency in less than a year — comes after sharp criticism of his handling of drug ...

WASHINGTON (AP) — A Food and Drug Administration official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to step down at the urging of ...

Welcome to another installment of This Week at FDA, your weekly source for updates—big and small—on FDA, drug, and medical device regulation and what we’re reading from around the web. This week, ...

Knoepfler is a professor of cell biology and human anatomy at UC Davis School of Medicine and writes STAT’s Lab Dish column. Vinay Prasad’s short yet two-act tenure at the FDA was wild. How does ...

Editor’s note: This article was updated on 18 June 2025 to clarify aspects of Prasad’s new role. In an email to US Food and Drug Administration (FDA) staff on Wednesday, FDA Commissioner Martin Makary ...

Good news: Vinay Prasad on Thursday served his final day at the Food and Drug Administration. Now the bad news: Commissioner Marty Makary has tapped Dr. Prasad’s deputy, Katherine Szarama, to replace ...

Prasad remains a vocal critic of mask mandates and fast-tracked COVID boosters that became controversial issues during pandemic lockdowns. The U.S. Food and Drug Administration announced Tuesday Vinay ...

The Wall Street Journal editorial board has accused FDA Commissioner Marty Makary’s outgoing subordinate, Vinay Prasad, of making false claims about the rejection of Replimune’s melanoma drug RP1. In ...